Condition
Tissue Expansion
Total Trials
5
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 1 (1)
Trial Status
Unknown3
Withdrawn1
Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT05975372Not ApplicableRecruitingPrimary
Blossom® Smart Expander Device for Tissue Expander/Implant-Based Breast Reconstruction
NCT04781907Not ApplicableWithdrawnPrimary
Patient Performed Tissue Expansion for Two-stage Alloplastic Breast Reconstruction
NCT03586960Not ApplicableUnknown
Use of a Novel Device for Stretch Relaxation During Mohs Surgery
NCT03084887Not ApplicableUnknownPrimary
Study of Tissue Expansion Devices Complications
NCT01209611Phase 1UnknownPrimary
Autologous Bone Marrow-Derived Mononuclear Cell Transplantation in Accelerating Tissue Expansion and Skin Regeneration
Showing all 5 trials